Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Culturally adapted therapies for early psychosis in Pakistan

Official title: Culturally Adapted Psychosocial Interventions for Early Psychosis in a Low-resource Setting: a Large Multi-center Randomised Controlled Trial

Run by Pakistan Institute of Living and Learning · NCT05814913 · Data updated 2026-11-12

This study is testing if specially adapted therapy programs can help people in Pakistan who are experiencing their first episode of psychosis feel better compared to standard treatment.

More Psychosis trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment390 (estimated)
SponsorPakistan Institute of Living and Learning
Academic / other
Locations1 site (Karachi, Sindh)
StatusRecruiting
StartedApril 15, 2024
Main results expectedJune 30, 2026
Study endsDecember 31, 2026
Registry record updatedDecember 12, 2024
Trial IDNCT05814913 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals over 18 years old with a confirmed diagnosis of schizophrenia or related disorders, experiencing their first episode of psychosis, and who have a supportive carer willing to participate.

Probably not a fit

Patients with active substance use disorders or severe cognitive disorganization may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effectiveness of Culturally adapted Cognitive Behavioral Therapy (CaCBT) and Culturally adapted Family Intervention (CulFI) in reducing symptoms of psychosis in individuals experiencing their first episode of psychosis in Pakistan. The study will involve 390 participants who will be randomly assigned to receive either CaCBT, CulFI, or Treatment As Usual (TAU). Participants will undergo a series of therapy sessions delivered by trained psychologists, with assessments conducted at multiple time points to measure outcomes related to psychosis symptoms, quality of life, and caregiver wellbeing. The study also seeks to assess the economic impact of these interventions in a low-resource setting.

Why it matters

Potential benefit: If successful, this study could provide effective, culturally tailored interventions for individuals with early psychosis, improving their symptoms and overall quality of life.

How similar studies have gone: While there is limited evidence from low- and middle-income countries regarding the efficacy of these culturally adapted interventions, similar approaches have shown promise in other settings.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria for patient participants:

* Individuals of all genders aged over 18 years; diagnosis of schizophrenia confirmed by Structured Clinical Interview for DSM (SCID) meeting DSM-5 criteria for schizophrenia, schizophreniform or schizoaffective psychosis
* Scored at least 4 on the PANSS delusions or hallucinations items, or at least 5 on suspiciousness, persecution, or grandiosity items
* stable on medication for the past four weeks
* in contact with mental health services
* within 3 years of diagnosis
* able to demonstrate the capacity to provide informed consent to take part in the study
* potential participants must have a carer or relative who is also willing to participate in the study to be eligible

Exclusion Criteria for patient participants:

* Active DSM-5 substance use disorder (except nicotine or caffeine) or dependence within the last three months
* A score of 5 or more on the PANSS conceptual disorganisation item
* Individuals who have received structured psychological intervention within the past 3 months
* Relevant CNS or other medical disorders that would impact participation
* Diagnosis of intellectual disability
* Unstable residential arrangements

Family member/Carer participant inclusion criteria:

* Living with or spending at least 10 hours per week in face-to-face contact with an individual with early psychosis and assuming a caring role
* Age\>18 years
* Able to give informed written consent.

Family member/Carer participant exclusion criteria:

* Active DSM-5 substance use disorder
* Received psychological intervention within the past 3 months
* Unstable residential arrangements.

Where it's running

  • Civil hospital
    Karachi, Sindh, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.